Articles published by Pulse Biosciences, Inc.

Home
- Contact Us
- Terms of Use
- Privacy Policy
- Subscription Services
- Submission Forms
- Place an Ad
- Promote Your Event
- Local Weather
  
  Recent Quotes
  
  View Full List
  
  My Watchlist
  
  Create Watchlist
  
  Indicators
  
  DJI
  
  Nasdaq Composite
  
  SPX
  
  Gold
  
  Crude Oil
  
  Markets
  
  Stocks
  
  ETFs
  
  Tools
  
  Markets:
  
  Overview
  
  News
  
  Currencies
  
  International
  
  Treasuries
  
  Articles published by Pulse Biosciences, Inc.
  
  < Previous 1 2 3 4 5 Next >
  
  Pulse Biosciences Announces Positive 60-Day Follow-Up Evaluations for Initial Patients treated in the CellFX® nsPFA™ 360° Cardiac Catheter First-in-Human Feasibility Study
  February 14, 2024
  
  From Pulse Biosciences, Inc.
  
  Via Business Wire
  
  Tickers PLSE
  
  Pulse Biosciences Announces Preliminary Findings from its CellFX nsPFA 360 Cardiac Catheter First-In-Human Feasibility Study to be Featured in Podium Presentation at the AF Symposium
  January 31, 2024
  
  From Pulse Biosciences, Inc.
  
  Via Business Wire
  
  Tickers PLSE
  
  Pulse Biosciences Files 510(k) Submission with U.S. FDA for its CellFX® nsPFA™ Cardiac Clamp
  January 02, 2024
  
  From Pulse Biosciences, Inc.
  
  Via Business Wire
  
  Tickers PLSE
  
  Pulse Biosciences Announces First-in-Human Procedures with its Novel CellFX™ Nanosecond Pulsed Field Ablation (nsPFA™) Cardiac Catheter
  December 20, 2023
  
  From Pulse Biosciences, Inc.
  
  Via Business Wire
  
  Tickers PLSE
  
  Pulse Biosciences Files 510(k) Submission with U.S. FDA for its CellFX nsPFA Percutaneous Electrode
  November 21, 2023
  
  From Pulse Biosciences, Inc.
  
  Via Business Wire
  
  Tickers PLSE
  
  Pulse Biosciences to Present at the 35th Annual Piper Sandler Healthcare Conference
  November 15, 2023
  
  From Pulse Biosciences, Inc.
  
  Via Business Wire
  
  Tickers PLSE
  
  Pulse Biosciences Reports Business Updates and Third Quarter 2023 Financial Results
  November 13, 2023
  
  From Pulse Biosciences, Inc.
  
  Via Business Wire
  
  Tickers PLSE
  
  UPDATE Pulse Biosciences Announces New Time for Third Quarter 2023 Financial Results Conference Call
  November 10, 2023
  
  From Pulse Biosciences, Inc.
  
  Via Business Wire
  
  Tickers PLSE
  
  Pulse Biosciences Schedules Third Quarter 2023 Financial Results Conference Call for November 13, 2023
  October 30, 2023
  
  From Pulse Biosciences, Inc.
  
  Via Business Wire
  
  Tickers PLSE
  
  Pulse Biosciences Appoints Dr. Niv Ad as Chief Science Officer, Cardiac Surgery
  October 24, 2023
  
  From Pulse Biosciences, Inc.
  
  Via Business Wire
  
  Tickers PLSE
  
  Pulse Biosciences Announces Collaboration with CardioNXT for nsPFA First-in-Human Atrial Fibrillation Study
  October 02, 2023
  
  From Pulse Biosciences, Inc.
  
  Via Business Wire
  
  Tickers PLSE
  
  Pulse Biosciences’ Nanosecond Pulsed Field Ablation (nsPFA™) Circumferential Catheter System to be Featured in a Presentation at the Global EP Summit
  September 29, 2023
  
  From Pulse Biosciences, Inc.
  
  Via Business Wire
  
  Tickers PLSE
  
  Pulse Biosciences’ First Study in a Surgical Application of Nanosecond Pulsed Field Ablation (nsPFA) Technology to be Featured in Two Poster Presentations at the American Thyroid Association Annual Meeting
  September 27, 2023
  
  From Pulse Biosciences, Inc.
  
  Via Business Wire
  
  Tickers PLSE
  
  Pulse Biosciences to Present at Gilmartin Group Emerging Growth Showcase
  September 07, 2023
  
  From Pulse Biosciences, Inc.
  
  Via Business Wire
  
  Tickers PLSE
  
  Pulse Biosciences Clarifies Details of Recent S-3 Filing
  August 24, 2023
  
  From Pulse Biosciences, Inc.
  
  Via Business Wire
  
  Tickers PLSE
  
  Pulse Biosciences Reports Business Updates and Second Quarter 2023 Financial Results
  August 10, 2023
  
  From Pulse Biosciences, Inc.
  
  Via Business Wire
  
  Tickers PLSE
  
  Pulse Biosciences Schedules Second Quarter 2023 Financial Results Conference Call for August 10, 2023
  July 27, 2023
  
  From Pulse Biosciences, Inc.
  
  Via Business Wire
  
  Tickers PLSE
  
  Pulse Biosciences’ Nanosecond Pulsed Field Ablation (nsPFA™) Technology to be Featured in Several Presentations at The Heart Rhythm 2023 Annual Meeting
  May 18, 2023
  
  From Pulse Biosciences, Inc.
  
  Via Business Wire
  
  Tickers PLSE
  
  Pulse Biosciences Reports Business Updates and First Quarter 2023 Financial Results
  May 11, 2023
  
  From Pulse Biosciences, Inc.
  
  Via Business Wire
  
  Tickers PLSE
  
  Pulse Biosciences, Inc. Announces Planned Redemption of Warrants
  May 10, 2023
  
  From Pulse Biosciences, Inc.
  
  Via Business Wire
  
  Tickers PLSE
  
  Pulse Biosciences, Inc. Appoints Dr. Gan Dunnington as Chief Medical Officer
  May 03, 2023
  
  From Pulse Biosciences, Inc.
  
  Via Business Wire
  
  Tickers PLSE
  
  Pulse Biosciences Announces $65 Million Private Placement
  May 01, 2023
  
  From Pulse Biosciences, Inc.
  
  Via Business Wire
  
  Tickers PLSE
  
  Pulse Biosciences Schedules First Quarter 2023 Financial Results Conference Call for May 11, 2023
  April 27, 2023
  
  From Pulse Biosciences, Inc.
  
  Via Business Wire
  
  Tickers PLSE
  
  Pulse Biosciences Reports Fourth Quarter & Full Year 2022 Financial Results
  March 30, 2023
  
  From Pulse Biosciences, Inc.
  
  Via Business Wire
  
  Tickers PLSE
  
  Pulse Biosciences Schedules Fourth Quarter & Full Year 2022 Financial Results Conference Call for March 30, 2023
  March 02, 2023
  
  From Pulse Biosciences, Inc.
  
  Via Business Wire
  
  Tickers PLSE
  
  Pulse Biosciences Reports Third Quarter 2022 Financial Results
  November 10, 2022
  
  From Pulse Biosciences, Inc.
  
  Via Business Wire
  
  Tickers PLSE
  
  Pulse Biosciences Schedules Third Quarter 2022 Financial Results Conference Call for November 10, 2022
  October 27, 2022
  
  From Pulse Biosciences, Inc.
  
  Via Business Wire
  
  Tickers PLSE
  
  Pulse Biosciences Announces Positive Clinical Data on Nano-Pulse Stimulation Procedure for Low-Risk Basal Cell Carcinoma Lesions
  October 06, 2022
  
  From Pulse Biosciences, Inc.
  
  Via Business Wire
  
  Tickers PLSE
  
  Pulse Biosciences Announces FDA 510(k) Clearance for the Treatment of Sebaceous Hyperplasia
  September 26, 2022
  
  From Pulse Biosciences, Inc.
  
  Via Business Wire
  
  Tickers PLSE
  
  Pulse Biosciences Announces Strategic Change of Focus in Support of Significant Additional Opportunities for medicinal related Nano-Pulse Stimulation
  September 20, 2022
  
  From Pulse Biosciences, Inc.
  
  Via Business Wire
  
  Tickers PLSE
  
  < Previous 1 2 3 4 5 Next >
  
  Stock Quote API & Stock News API supplied by www.cloudquote.io
  Quotes delayed at least 20 minutes.
  By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  © 2025 FinancialContent. All rights reserved.

Newport, VT (05855)

Today

Tonight

Articles published by Pulse Biosciences, Inc.